Finance

There are worthwhile investment themes beyond artificial intelligence.

A disappointing raise may signal the acceleration of the depletion of the Social Security trust fund.

Concerns about the sustainability of the company’s dividend are fading fast.

Three high-octane income stocks — sporting an average yield of 6.23% — have the necessary tools and intangibles to make their patient shareholders richer.

Investing in growth stocks can be a lucrative opportunity for long-term investors.

A new high could be the peak or the market could keep going up. Here’s what’s more likely.

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

Could rebounds be in store for these beaten-down stocks?

Broadcom shares have jumped 3% since the company announced a stock split in June.

Two stock-split stocks that are veritable monopolies within their respective industries could go in opposite directions in the fourth quarter (and beyond).

Nvidia’s revenue is already soaring. But could more major gains be ahead?

Lower interest rates may leave companies and individuals with more money to spend and invest…

This exchange-traded fund holds 231 of the top-performing growth stocks from the S&P 500 index.

Which of these high-growth e-commerce companies has more upside potential?

Coca-Cola is an iconic company with an incredible dividend track record. Prepare to buy it today so you are ready when it goes on sale again.

Demand for blood glucose monitors is strong, but DexCom isn’t the only competitor in this lucrative market.

A 5.8% forward-dividend yield is just one reason the hedge fund manager likes this stock.

We’re close to an official announcement, but here’s what to expect.

NKE earnings call for the period ending September 30, 2024.

Sales are reportedly weak at a key partner.